{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:39:06Z","timestamp":1787787546136,"version":"build-2784847793"},"reference-count":109,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.celrep.2022.111769","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:00:30Z","timestamp":1670328030000},"page":"111769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Cancer cell-derived type I interferons instruct tumor monocyte polarization"],"prefix":"10.1016","volume":"41","author":[{"given":"Dylan","family":"Kwart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhashini","family":"Srivatsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Lett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquelynn","family":"Golubov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin M.","family":"Oswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle","family":"Waite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arielle Glatman","family":"Zaretsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7430-3464","authenticated-orcid":false,"given":"Sokol","family":"Haxhinasto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7629-7160","authenticated-orcid":false,"given":"Elsa","family":"Au-Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4517-1546","authenticated-orcid":false,"given":"Namita T.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4200-788X","authenticated-orcid":false,"given":"Samvitha","family":"Cherravuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Malahias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Negron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6382-0848","authenticated-orcid":false,"given":"Min","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurinder S.","family":"Atwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Stokes","family":"Oristian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Poueymirou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Fury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Lowy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Sleeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1639-584X","authenticated-orcid":false,"given":"Bei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Skokos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2022.111769_bib1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.immuni.2018.10.005","article-title":"Developmental and functional heterogeneity of monocytes","volume":"49","author":"Guilliams","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111769_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri.2017.28","article-title":"Monocyte differentiation and antigen-presenting functions","volume":"17","author":"Jakubzick","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2022.111769_bib3","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.4049\/jimmunol.0902583","article-title":"Inflammatory blood monocytes contribute to tumor development and represent a privileged target to improve host immunosurveillance","volume":"185","author":"Augier","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111769_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.celrep.2022.111769_bib5","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111769_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2011.09.034","article-title":"Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level","volume":"124","author":"Lee","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.celrep.2022.111769_bib7","doi-asserted-by":"crossref","first-page":"e41658","DOI":"10.1371\/journal.pone.0041658","article-title":"Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2022.111769_bib8","doi-asserted-by":"crossref","first-page":"e108062","DOI":"10.1371\/journal.pone.0108062","article-title":"Prognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: based on a large cohort study","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2022.111769_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7150\/jca.13432","article-title":"The lymphocyte-monocyte ratio predicts patient survival and aggressiveness of ovarian cancer","volume":"7","author":"Eo","year":"2016","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/j.celrep.2022.111769_bib10","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/leu.2011.112","article-title":"The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma","volume":"25","author":"Wilcox","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.celrep.2022.111769_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/bjc.2013.785","article-title":"The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer","volume":"110","author":"Stotz","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.celrep.2022.111769_bib12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111769_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2022.111769_bib14","doi-asserted-by":"crossref","first-page":"eaax8189","DOI":"10.1126\/sciimmunol.aax8189","article-title":"GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment","volume":"4","author":"Halaby","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2022.111769_bib15","doi-asserted-by":"crossref","first-page":"eaay6017","DOI":"10.1126\/sciimmunol.aay6017","article-title":"Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics","volume":"5","author":"Alshetaiwi","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2022.111769_bib16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2022.111769_bib17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00262-016-1953-z","article-title":"Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients","volume":"66","author":"Jordan","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2022.111769_bib18","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s00262-013-1475-x","article-title":"Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients","volume":"62","author":"Jordan","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2022.111769_bib19","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00262-011-1028-0","article-title":"Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13","volume":"60","author":"Gabitass","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2022.111769_bib20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.intimp.2018.08.007","article-title":"Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab","volume":"63","author":"Tobin","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.celrep.2022.111769_bib21","doi-asserted-by":"crossref","first-page":"237ra67","DOI":"10.1126\/scitranslmed.3007974","article-title":"Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy","volume":"6","author":"Highfill","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2022.111769_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00262-013-1508-5","article-title":"Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab","volume":"63","author":"Meyer","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2022.111769_bib23","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1158\/1078-0432.CCR-15-3104","article-title":"Clinical significance of circulating CD33+CD11b+HLA-DR\u2212 myeloid cells in patients with stage IV melanoma treated with ipilimumab","volume":"22","author":"Sade-Feldman","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2022.111769_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nm.4466","article-title":"High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy","volume":"24","author":"Krieg","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111769_bib25","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.aac9407","article-title":"Patrolling monocytes control tumor metastasis to the lung","volume":"350","author":"Hanna","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111769_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nature16985","article-title":"Visualization of immediate immune responses to pioneer metastatic cells in the lung","volume":"531","author":"Headley","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111769_bib27","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1084\/jem.189.8.1343","article-title":"Monocyte-mediated tumoricidal activity via the tumor necrosis factor\u2013related cytokine, TRAIL","volume":"189","author":"Griffith","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2022.111769_bib28","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.celrep.2017.10.024","article-title":"A discrete subset of monocyte-derived cells among typical conventional type 2 dendritic cells can efficiently cross-present","volume":"21","author":"Sheng","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.111769_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.immuni.2017.12.014","article-title":"Activation of p53 in immature myeloid precursor cells controls differentiation into Ly6c+CD103+ monocytic antigen-presenting cells in tumors","volume":"48","author":"Sharma","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111769_bib30","doi-asserted-by":"crossref","first-page":"eaat1500","DOI":"10.1126\/scitranslmed.aat1500","article-title":"Human tumor-associated monocytes\/macrophages and their regulation of T\u00a0cell responses in early-stage lung cancer","volume":"11","author":"Singhal","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2022.111769_bib31","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI128267","article-title":"Antigen-loaded monocyte administration induces potent therapeutic anti-tumor T\u00a0cell responses","volume":"130","author":"Huang","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2022.111769_bib32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.immuni.2017.07.014","article-title":"Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression","volume":"47","author":"Zhu","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111769_bib33","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1158\/2326-6066.CIR-17-0082","article-title":"Primary tumors limit metastasis formation through induction of IL15-mediated cross-talk between patrolling monocytes and NK cells","volume":"5","author":"Kubo","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.celrep.2022.111769_bib34","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41467-017-01433-3","article-title":"Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche","volume":"8","author":"Plebanek","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111769_bib35","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1073\/pnas.1417320112","article-title":"Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T\u00a0cells ex\u00a0vivo by nonclassical monocytes in melanoma patients","volume":"112","author":"Romano","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111769_bib36","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1016\/j.cell.2021.09.019","article-title":"Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment","volume":"184","author":"Lam","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111769_bib37","doi-asserted-by":"crossref","first-page":"e000588","DOI":"10.1136\/jitc-2020-000588","article-title":"Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy","volume":"8","author":"Schetters","year":"2020","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.celrep.2022.111769_bib38","doi-asserted-by":"crossref","first-page":"e1232222","DOI":"10.1080\/2162402X.2016.1232222","article-title":"Regulation of myeloid cells by activated T\u00a0cells determines the efficacy of PD-1 blockade","volume":"5","author":"Eissler","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.celrep.2022.111769_bib39","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1158\/0008-5472.CAN-13-3723","article-title":"CSF1\/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models","volume":"74","author":"Zhu","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2022.111769_bib40","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1158\/0008-5472.CAN-19-2843","article-title":"Tumor-derived prostaglandin E2 promotes p50 NF-\u03baB-Dependent differentiation of monocytic MDSCs","volume":"80","author":"Porta","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2022.111769_bib41","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/2326-6066.CIR-19-0008","article-title":"TAM family receptor kinase inhibition reverses MDSC-mediated suppression and augments anti\u2013PD-1 therapy in melanoma","volume":"7","author":"Holtzhausen","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.celrep.2022.111769_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s40425-017-0308-4","article-title":"Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment","volume":"5","author":"Steggerda","year":"2017","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.celrep.2022.111769_bib43","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/2159-8290.CD-15-1032","article-title":"IFN\u03b3 and CCL2 cooperate to redirect tumor-infiltrating monocytes to degrade fibrosis and enhance chemotherapy efficacy in pancreatic carcinoma","volume":"6","author":"Long","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2022.111769_bib44","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","article-title":"Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111769_bib45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41388-020-01528-0","article-title":"Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations","volume":"40","author":"He","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2022.111769_bib46","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","article-title":"Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species","volume":"50","author":"Zilionis","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111769_bib47","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1172\/JCI79590","article-title":"Disabled homolog 2 controls macrophage phenotypic polarization and adipose tissue inflammation","volume":"126","author":"Adamson","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2022.111769_bib48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4049\/jimmunol.1500257","article-title":"Monocyte stabilin-1 suppresses the activation of Th1 lymphocytes","volume":"196","author":"Palani","year":"2016","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111769_bib49","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1038\/s41467-020-18546-x","article-title":"A gene expression signature of TREM2hi macrophages and \u03b3\u03b4 T\u00a0cells predicts immunotherapy response","volume":"11","author":"Xiong","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111769_bib50","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41588-020-0636-z","article-title":"Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer","volume":"52","author":"Lee","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2022.111769_bib51","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nmeth.4380","article-title":"Simultaneous epitope and transcriptome measurement in single cells","volume":"14","author":"Stoeckius","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2022.111769_bib52","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1158\/0008-5472.CAN-04-0465","article-title":"Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses","volume":"64","author":"Rodriguez","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2022.111769_bib53","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.yexcr.2017.08.028","article-title":"Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma","volume":"359","author":"Zhang","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.celrep.2022.111769_bib54","doi-asserted-by":"crossref","first-page":"565383","DOI":"10.3389\/fmolb.2020.565383","article-title":"The significance of secreted phosphoprotein 1 in multiple human cancers","volume":"7","author":"Wei","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.celrep.2022.111769_bib55","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.cmet.2019.07.015","article-title":"Podoplanin-expressing macrophages promote lymphangiogenesis and lymphoinvasion in breast cancer","volume":"30","author":"Bieniasz-Krzywiec","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2022.111769_bib56","first-page":"547179","article-title":"Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages","volume":"2010","author":"Allavena","year":"2010","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.celrep.2022.111769_bib57","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","article-title":"STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors","volume":"41","author":"Deng","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111769_bib58","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.immuni.2018.09.016","article-title":"Tumor-derived cGAMP triggers a STING-mediated interferon response in non-tumor cells to activate the NK cell response","volume":"49","author":"Marcus","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111769_bib59","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.celrep.2019.09.065","article-title":"Cancer-cell-intrinsic cGAS expression mediates tumor immunogenicity","volume":"29","author":"Schadt","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.111769_bib60","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111769_bib61","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm.3708","article-title":"Cancer cell\u2013autonomous contribution of type I interferon signaling to the efficacy of chemotherapy","volume":"20","author":"Sistigu","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111769_bib62","doi-asserted-by":"crossref","first-page":"e32542","DOI":"10.1371\/journal.pone.0032542","article-title":"Chemotherapeutics and radiation stimulate MHC class I expression through elevated interferon-beta signaling in breast cancer cells","volume":"7","author":"Wan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2022.111769_bib63","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1158\/2326-6066.CIR-16-0060","article-title":"Response to programmed cell death-1 blockade in a murine melanoma syngeneic model requires costimulation, CD4, and CD8 T\u00a0cells","volume":"4","author":"Homet Moreno","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.celrep.2022.111769_bib64","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/ncb3371","article-title":"Suppression of microRNA activity amplifies IFN-\u03b3-induced macrophage activation and promotes anti-tumour immunity","volume":"18","author":"Baer","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.celrep.2022.111769_bib65","article-title":"Characterization of neoantigen-specific T\u00a0cells in cancer resistant to immune checkpoint therapies","volume":"118","author":"Li","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111769_bib66","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41467-017-02424-0","article-title":"Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution","volume":"9","author":"Efremova","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111769_bib67","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/genes8090230","article-title":"Satellite DNA: an evolving topic","volume":"8","author":"Garrido-Ramos","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.celrep.2022.111769_bib68","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12935-019-1091-8","article-title":"Microsatellite instability: a review of what the oncologist should know","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.celrep.2022.111769_bib69","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ccell.2020.11.006","article-title":"DNA sensing in mismatch repair-deficient tumor cells is essential for anti-tumor immunity","volume":"39","author":"Lu","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2022.111769_bib70","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2022.111769_bib71","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1200\/JCO.2018.36.4_suppl.554","article-title":"Nivolumab in patients with DNA mismatch repair-deficient\/microsatellite instability-high (dMMR\/MSI-H) metastatic colorectal cancer (mCRC): long-term survival according to prior line of treatment from CheckMate-142","volume":"36","author":"Overman","year":"2018","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.celrep.2022.111769_bib72","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3389\/fimmu.2020.02039","article-title":"Crosstalk between the MSI status and tumor microenvironment in colorectal cancer","volume":"11","author":"Lin","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2022.111769_bib73","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1805131","article-title":"PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma","volume":"379","author":"Migden","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2022.111769_bib74","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-021-03651-8","article-title":"Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells","volume":"595","author":"Casanova-Acebes","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111769_bib75","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","article-title":"Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease","volume":"54","author":"Mulder","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111769_bib76","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2022.111769_bib77","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/JLB.4RI0818-311R","article-title":"Monocyte heterogeneity and functions in cancer","volume":"106","author":"Olingy","year":"2019","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.celrep.2022.111769_bib78","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00262-019-02302-2","article-title":"Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates","volume":"68","author":"Cassetta","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2022.111769_bib79","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111769_bib80","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.4049\/jimmunol.172.9.5363","article-title":"Role of cross-talk between IFN-\u03b1-Induced monocyte-derived dendritic cells and NK cells in priming CD8+ T\u00a0cell responses against human tumor antigens","volume":"172","author":"Tosi","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111769_bib81","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.4049\/jimmunol.180.3.1462","article-title":"IFN-\u03b1 skews monocytes into CD56+-expressing dendritic cells with potent functional activities in\u00a0vitro and in\u00a0vivo","volume":"180","author":"Papewalis","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111769_bib82","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.191.10.1777","article-title":"Type I interferon as a powerful adjuvant forMonocyte-derived dendritic cell development and activity in\u00a0vitro and in hu-PBL-SCID mice","volume":"191","author":"Santini","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2022.111769_bib83","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1182\/blood-2003-03-0981","article-title":"IFN-\u03b1 promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment","volume":"103","author":"Gabriele","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2022.111769_bib84","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1126\/science.1064890","article-title":"Induction of dendritic cell differentiation by IFN-\u03b1 in systemic lupus erythematosus","volume":"294","author":"Blanco","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111769_bib85","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.4049\/jimmunol.170.10.5195","article-title":"Monocyte-derived dendritic cells generated after a short-term culture with IFN-\u03b1 and granulocyte-macrophage colony-stimulating factor stimulate a potent epstein-Barr virus-specific CD8+ T\u00a0cell response","volume":"170","author":"Santodonato","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111769_bib86","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/jir.2006.0083","article-title":"Clinical model interferons activate human monocytes to an eradicative tumor cell level in\u00a0vitro","volume":"27","author":"Baron","year":"2007","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.celrep.2022.111769_bib87","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/jir.2014.0057","article-title":"Human monocytes in the presence of interferons Alpha2a and gamma are potent killers of serous ovarian cancer cell lines in combination with paclitaxel and carboplatin","volume":"35","author":"Johnson","year":"2015","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.celrep.2022.111769_bib88","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00262-011-1152-x","article-title":"Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors","volume":"61","author":"Nakashima","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2022.111769_bib89","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s40425-019-0697-7","article-title":"Natural killer T\u00a0cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor","volume":"7","author":"Paul","year":"2019","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.celrep.2022.111769_bib90","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3389\/fimmu.2017.01383","article-title":"Toll-like receptor ligands and interferon-\u03b3 synergize for induction of antitumor M1 macrophages","volume":"8","author":"M\u00fcller","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2022.111769_bib91","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s43018-020-0028-4","article-title":"Extracellular cGAMP is a cancer-cell-produced immunotransmitter involved in radiation-induced anticancer immunity","volume":"1","author":"Carozza","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.celrep.2022.111769_bib92","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/s41467-021-22033-2","article-title":"Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway","volume":"12","author":"Alicea-Torres","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111769_bib93","doi-asserted-by":"crossref","first-page":"e106065","DOI":"10.15252\/embj.2020106065","article-title":"5-Fluorouracil efficacy requires anti-tumor immunity triggered by cancer-cell-intrinsic STING","volume":"40","author":"Tian","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2022.111769_bib94","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1038\/sj.gt.3301034","article-title":"Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models","volume":"6","author":"Hiroishi","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.celrep.2022.111769_bib95","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/cgt.2012.42","article-title":"Effects of interferon-\u03b1-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors","volume":"19","author":"Omori","year":"2012","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.celrep.2022.111769_bib96","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41591-018-0302-5","article-title":"Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss","volume":"25","author":"Liu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111769_bib97","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1038\/s41467-018-07824-4","article-title":"Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells","volume":"9","author":"Gannon","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111769_bib98","doi-asserted-by":"crossref","first-page":"1902880","DOI":"10.1002\/advs.201902880","article-title":"ImmuCellAI: a unique method for comprehensive T-cell subsets abundance prediction and its application in cancer immunotherapy","volume":"7","author":"Miao","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.celrep.2022.111769_bib99","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nbt1263","article-title":"F0 generation mice fully derived from gene-targeted embryonic stem cells allowing immediate phenotypic analyses","volume":"25","author":"Poueymirou","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2022.111769_bib100","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nbt822","article-title":"High-throughput engineering of the mouse genome coupled with high-resolution expression analysis","volume":"21","author":"Valenzuela","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2022.111769_bib101","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2022.111769_bib102","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13059-018-1603-1","article-title":"Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics","volume":"19","author":"Stoeckius","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2022.111769_bib103","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111769_bib104","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1140\/epjb\/e2013-40829-0","article-title":"A smart local moving algorithm for large-scale modularity-based community detection","volume":"86","author":"Waltman","year":"2013","journal-title":"Eur. Phys. J. B"},{"key":"10.1016\/j.celrep.2022.111769_bib105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2164-10-22","article-title":"BioMart\u00a0\u2013 biological queries made easy","volume":"10","author":"Smedley","year":"2009","journal-title":"BMC Genom."},{"key":"10.1016\/j.celrep.2022.111769_bib106","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01825-16","article-title":"CD8+ T\u00a0cells and macrophages regulate pathogenesis in a mouse model of Middle East respiratory syndrome","volume":"91","author":"Coleman","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.111769_bib107","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","article-title":"Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences","volume":"4","author":"Soneson","year":"2015","journal-title":"F1000Res."},{"key":"10.1016\/j.celrep.2022.111769_bib108","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2022.111769_bib109","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722016527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722016527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:54:48Z","timestamp":1761911688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124722016527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":109,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2211124722016527"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2022.111769","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer cell-derived type I interferons instruct tumor monocyte polarization","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2022.111769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"111769"}}